Balyasny Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,100
Closed -$8.67M 3031
2025
Q1
$8.67M Buy
25,100
+24,400
+3,486% +$7.85M 0.01% 998
2024
Q4
$210K Sell
700
-1,700
-71% -$594K ﹤0.01% 2516
2024
Q3
$975K Buy
+2,400
New +$879K ﹤0.01% 1978
2024
Q2
Sell
-1,200
Closed -$400K 2784
2024
Q1
$400K Buy
1,200
+300
+33% +$91.7K ﹤0.01% 2142
2023
Q4
$244K Buy
+900
New +$222K ﹤0.01% 2248
2023
Q3
Sell
-156,000
Closed -$47.3M 2450
2023
Q2
$47.3M Buy
+156,000
New +$43.4M 0.1% 267
2021
Q4
Sell
-5,000
Closed -$1.21M 2383
2021
Q3
$1.21M Buy
+5,000
New +$1.22M 0.01% 1279
2020
Q2
Sell
-40,000
Closed -$3.59M 1280
2020
Q1
$3.59M Buy
+40,000
New +$5.18M 0.04% 484
2019
Q3
Sell
-25,000
Closed -$3.21M 1340
2019
Q2
$3.21M Buy
+25,000
New +$3.16M 0.02% 739
2017
Q4
Sell
-75,000
Closed -$5.97M 2150
2017
Q3
$5.97M Buy
+75,000
New +$6.03M 0.02% 654
2015
Q3
Sell
-100,000
Closed -$9.07M 1237
2015
Q2
$9.07M Buy
+100,000
New +$8.01M 0.06% 421
2014
Q3
Sell
-100,000
Closed -$5.64M 770
2014
Q2
$5.64M Buy
+100,000
New +$5.28M 0.06% 350

Other funds holding HCA

Balyasny Asset Management's HCA Position: Q1 2026 in Review

Balyasny Asset Management reduced its HCA Healthcare (HCA) stake by 48% in Q1 2026, selling an estimated $1.15M and leaving 2,508 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2013.

Balyasny Asset Management first reported a position in HCA in Q2 2013 and has held it in 41 quarters since. The position peaked at $63.9M in Q4 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Balyasny Asset Management held 2,508 shares of HCA Healthcare worth $1.19M as of Q1 2026.
  • Balyasny Asset Management sold 2,280 HCA Healthcare shares in Q1 2026, an estimated $1.15M.
  • HCA Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2013 holding.
  • Balyasny Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 41 quarters since.
  • Balyasny Asset Management's HCA Healthcare position peaked at $63.9M in Q4 2023.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.